Januvia Tablet, Film Coated
Product Images NDC 55154-5040

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 55154-5040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (Image 01)

Label for JANUVIA (sitagliptin) tablets 50 mg, a human prescription oral film-coated tablet. The label states each tablet contains 64.25 mg sitagliptin phosphate, equivalent to 50 mg sitagliptin. It includes dosage storage instructions, manufacturer details (Merck Sharp & Dohme Corp.), and distributor information (Cardinal Health 107, LLC). The label features barcodes and warnings to keep out of reach of children.*

FDA Label Image

Image Of Sitagliptin Chemical Structure (Januvia 01)

Chemical structure of sitagliptin in its phosphate and hydrate form, shown with atomic connections and functional groups including trifluoromethyl and fluorophenyl moieties.*

FDA Label Image

Image Of Figure 1 (Januvia 02)

A line graph depicting the least squares mean change from baseline over 24 weeks for various treatments including placebo, metformin (1000 mg and 500 mg b.i.d.), sitagliptin 100 mg q.d., and sitagliptin 50 mg b.i.d. combined with metformin (500 mg and 1000 mg b.i.d.). The x-axis represents the weeks (0 to 24) and the y-axis shows the LS mean change from baseline.*

FDA Label Image

Image Of Figure 2 (Januvia 03)

Line graph comparing the least squares mean change from baseline over 52 weeks between Januvia 100 mg and Glipizide. The x-axis represents weeks from 0 to 52, and the y-axis shows the LS mean change, with both treatments showing a decreasing trend that levels off after about 12 weeks and slightly increases toward week 52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.